Lan L - Search Results

1

The Crescentic Implication of Renal Outcomes in Proliferative Lupus Nephritis.

Cai F, Han F, Wang H, Han H, Le J, Lan L, Xu Y, Chen J. Cai F, et al. Among authors: lan l. J Rheumatol. 2018 Apr;45(4):513-520. doi: 10.3899/jrheum.170553. Epub 2018 Feb 15. J Rheumatol. 2018. PMID: 29449502

2

Efficacy and safety of rituximab therapy for systemic lupus erythematosus: a systematic review and meta-analysis.

Lan L, Han F, Chen JH. Lan L, et al. J Zhejiang Univ Sci B. 2012 Sep;13(9):731-44. doi: 10.1631/jzus.B1200057. J Zhejiang Univ Sci B. 2012. PMID: 22949364 Free PMC article. Review.

3

A survey of outcomes and management of patients post fragility fractures in China.

Wang O, Hu Y, Gong S, Xue Q, Deng Z, Wang L, Liu H, Tang H, Guo X, Chen J, Jia X, Xu Y, Lan L, Lei C, Dong H, Yuan G, Fu Q, Wei Y, Xia W, Xu L. Wang O, et al. Among authors: lan l. Osteoporos Int. 2015 Nov;26(11):2631-40. doi: 10.1007/s00198-015-3162-6. Epub 2015 May 13. Osteoporos Int. 2015. PMID: 25966892

4

Monocyte Chemotactic Protein-1, Fractalkine, and Receptor for Advanced Glycation End Products in Different Pathological Types of Lupus Nephritis and Their Value in Different Treatment Prognoses.

Lan L, Han F, Lang X, Chen J. Lan L, et al. PLoS One. 2016 Jul 26;11(7):e0159964. doi: 10.1371/journal.pone.0159964. eCollection 2016. PLoS One. 2016. PMID: 27458981 Free PMC article.

5

Early-stage predictors for treatment responses in patients with active lupus nephritis.

Liu G, Wang H, Le J, Lan L, Xu Y, Yang Y, Chen J, Han F. Liu G, et al. Among authors: lan l. Lupus. 2019 Mar;28(3):283-289. doi: 10.1177/0961203319826703. Epub 2019 Jan 25. Lupus. 2019. PMID: 30682900

6

Antiphospholipid Antibodies in Patients with Membranous Nephropathy.

Zhang Q, Wang Y, Xu Y, Lan L, Chen J, Han F. Zhang Q, et al. Among authors: lan l. Nephron. 2019;143(4):228-233. doi: 10.1159/000501857. Epub 2019 Aug 27. Nephron. 2019. PMID: 31454804

7

The correlation of anti-β2-glycoprotein I antibody with complement activation in patients with idiopathic membranous nephropathy.

Zhang Q, Wang Y, Ma Y, Jin L, Lan L, Ren P, Chen J, Han F. Zhang Q, et al. Among authors: lan l. Int Urol Nephrol. 2021 May;53(5):955-959. doi: 10.1007/s11255-020-02698-2. Epub 2021 Jan 3. Int Urol Nephrol. 2021. PMID: 33392885 Clinical Trial.

8

Performance of the 2019 EULAR/ACR systemic lupus erythematosus classification criteria in a cohort of patients with biopsy-confirmed lupus nephritis.

Wang H, Gao Y, Ma Y, Cai F, Huang X, Lan L, Ren P, Wang Y, Chen J, Han F. Wang H, et al. Among authors: lan l. Lupus Sci Med. 2021 Feb;8(1):e000458. doi: 10.1136/lupus-2020-000458. Lupus Sci Med. 2021. PMID: 33558437 Free PMC article.

9

Reduction of Bladder Cancer Chemosensitivity Induced by the Effect of HOXA-AS3 as a ceRNA for miR-455-5p That Upregulates Notch1.

Chen D, Xie S, Wu Y, Cui Y, Cai Y, Lan L, Yang H, Chen J, Chen W. Chen D, et al. Among authors: lan l. Front Oncol. 2021 Feb 12;10:572672. doi: 10.3389/fonc.2020.572672. eCollection 2020. Front Oncol. 2021. PMID: 33643896 Free PMC article.

10

The risk factors for early mortality and end-stage renal disease in anti-neutrophil cytoplasmic antibody-associated glomerulonephritis: experiences from a single center.

Ni A, Chen L, Huang X, Ma Y, Lan L, Ren P, Wang Y, Zhu Y, Xu Y, Chen J, Han F. Ni A, et al. Among authors: lan l. Clin Exp Med. 2021 Aug;21(3):389-397. doi: 10.1007/s10238-021-00690-3. Epub 2021 Mar 25. Clin Exp Med. 2021. PMID: 33768341

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,021 results

Search Page

Filters